IL18 and Abdominal obesity: Allaire et al. reported a significant decrease in plasma IL-6 (−12%), IL-18 (−7%), CRP (−8%), and TNF-α (−15%) for DHA compared to corn oil placebo in subjects with subclinical inflammation and abdominal obesity, whilst EPA resulted in a significant decrease in plasma IL-6 only (−13%) [52].